Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Ophthalmic findings associated with Australian tick paralysis (holocyclotoxicity) in hospitalized domestic dogs and cats.

Veterinary ophthalmology·2024
Same author

Feline distichiasis treated with cryoepilation: A retrospective study of 15 cats (27 eyes).

Veterinary ophthalmology·2024
Same author

Retrospective assessment of ophthalmic disease development in domestic dogs and cats when hospitalised with tick paralysis caused by Ixodes holocyclus.

Australian veterinary journal·2024
Same author

Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure.

International journal of cardiology·2022
Same author

[Unclear uveal tumor with bleeding].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same author

Author reply.

Internal medicine journal·2016

関連する実験動画

Updated: May 30, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

部分左心房切除術後の心筋運動の血液動力学.

K B James1, G Haas, S R Lutton

  • 1Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

Circulation
|November 18, 2000
PubMed
まとめ

部分左心房切除術 (PLV) を受けた患者は,運動中に心指数の改善を示しています. しかし,異常な肺圧力と酸素濃度の低下が持続し,手術後遅くにコンプライアンスに関する潜在的な問題を示唆しています.

科学分野:

  • 心臓病学 心臓病学
  • 心血管生理学 心血管の生理学
  • 心不全 手術 心不全 手術

背景:

  • 部分左心房切除術 (Partial left ventriculectomy,PLV) は,心不全を治療するための外科的処置である.
  • PLV後の患者報告の活動レベルは好ましい可能性があります.
  • PLVの後の運動生理学は,まだ完全に理解されていません.

研究 の 目的:

  • 部分左心房切除術後の患者における運動の血液動力学を記述する.
  • この患者グループにおける運動に対する生理学的反応を調査する.

主な方法:

  • 直立自転車の運動テストは,PLVの平均1.7年後の10人の患者 (9人の男性) で実施されました.
  • 肺動脈圧,肺毛細血管の圧,心臓指数,混合静脈酸化を含む血液動力学的パラメータが測定されました.
  • 運動中に肺血管抵抗も評価された.

主要な成果:

  • 心臓指数は運動で有意に増加しました (2.2〜3.8L/分/m2).
  • 肺動脈の圧力と肺毛細血管のの圧力は,運動中に著しく上昇した.
  • 混合静脈酸素化は,運動によって (44%から24%) 顕著に減少した.

さらに関連する動画

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model
08:37

Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model

Published on: June 3, 2021

関連する実験動画

Last Updated: May 30, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model
08:37

Blood Circuit Reconstruction in an Abdominal Mouse Heart Transplantation Model

Published on: June 3, 2021

結論:

  • PLV後期に,運動は心指数の有意な増加につながります.
  • 肺動脈とケイジ圧力の上昇は,異常な服従を示唆しています.
  • 混合静脈酸素化の有意な減少は,心不全管理の最適化のためのさらなる調査を保証します.